Literature DB >> 7917914

Tumours of the central nervous system and concentration of total serum cholesterol and beta-lipoprotein in men and women.

O Gatchev1, L Råstam, G Lindberg, B Gullberg, S Törnberg, G A Eklund.   

Abstract

Previous cross-sectional data suggest a positive association between serum cholesterol and brain neoplasms, but the results of cohort studies are inconclusive. There is evidence that in women the growth of meningiomas and astrocytomas depends on the hormonal status. The present investigation comprised data on serum cholesterol and beta-lipoprotein concentration among 229 participants in a health survey with subsequently diagnosed central nervous system (CNS) tumours. Data analyses included comparison of mean serum cholesterol and beta-lipoprotein level between cases and randomly selected controls--five for each case, matched for sex, age at screening and time of examination. The results showed a positive relation between the beta-lipoprotein level and the development of a CNS tumour (benign or malignant) in women under 50 years of age, and a negative association in those of older age with development of malignant tumours, which implies a possible influence of the menopausal status. Repeating the computations after excluding cases diagnosed within 5 years from screening revealed significant associations also between the serum cholesterol concentration and the development of a malignant CNS tumour, with a pattern similar to that of beta-lipoprotein. In conclusion, in women, irregular variation in the beta-lipoprotein level, which is involved in the synthesis of progesterone in the CNS, may enhance oncogenic transformation of astrocytes and meningeal cells; however, transformation of the latter is restricted to younger women.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917914      PMCID: PMC2033417          DOI: 10.1038/bjc.1994.368

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Neurology of sex steroids and oral contraceptives.

Authors:  H M Schipper
Journal:  Neurol Clin       Date:  1986-11       Impact factor: 3.806

2.  Plasma cholesterol concentration and primary brain tumours.

Authors:  G D Smith; M J Shipley
Journal:  BMJ       Date:  1989-07-01

3.  Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial.

Authors:  R W Sherwin; D N Wentworth; J A Cutler; S B Hulley; L H Kuller; J Stamler
Journal:  JAMA       Date:  1987-02-20       Impact factor: 56.272

Review 4.  Steroid hormones: humoral signals which alter brain cell properties and functions.

Authors:  B S McEwen; A Biegon; P G Davis; L C Krey; V N Luine; M Y McGinnis; C M Paden; B Parsons; T C Rainbow
Journal:  Recent Prog Horm Res       Date:  1982

Review 5.  The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands.

Authors:  J T Gwynne; J F Strauss
Journal:  Endocr Rev       Date:  1982       Impact factor: 19.871

6.  Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain.

Authors:  R E Pitas; J K Boyles; S H Lee; D Hui; K H Weisgraber
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

Review 7.  [Steroid receptors in the central nervous system. Implications in neurology].

Authors:  M Poisson; B F Pertuiset; M Moguilewsky; H Magdelenat; P M Martin
Journal:  Rev Neurol (Paris)       Date:  1984       Impact factor: 2.607

Review 8.  Pregnancy-related primary brain and spinal tumors.

Authors:  N C Roelvink; W Kamphorst; H A van Alphen; B R Rao
Journal:  Arch Neurol       Date:  1987-02

9.  Low-density lipoprotein receptor on endothelium of brain capillaries.

Authors:  S Méresse; C Delbart; J C Fruchart; R Cecchelli
Journal:  J Neurochem       Date:  1989-08       Impact factor: 5.372

10.  Serum cholesterol and primary brain tumours: a case-control study.

Authors:  Z H Abramson; J D Kark
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.